INTEGRA Biosciences has announced a new applications study, undertaken in conjunction with CEPower GmbH (Wädenswil, Switzerland), describing the advantages of a novel disposable flask bioreactor for cultivation of high levels of recombinant proteins in CHO cells.
A technical poster, describing this work, was short listed from a total of 232 submissions for the poster awards at the recent European Society for Animal Cell Technology (ESACT) 2005 meeting in Harrogate, UK.
|
|
The study shows that adherent CHO cells were successfully cultivated for several weeks in the CELLine adhere reaching a density of 1.6 x 10^7 cells / ml. This represents a 10-fold increase when compared to non-compartmentalised culture systems such as T-Flasks. As a result of this high cell density a 9-fold improvement in the productivity of the expressed recombinant protein was achieved. Additional benefits noted by the researchers in using the CELLine adhere included decreased volumes of supernatant, lower consumption of serum and lower use of consumables resulting in significant savings in the time, labour and material costs of protein production and downstream processing.
The study demonstrates that the CELLine adhere is an ideal tool for rapid and cost effective small scale manufacturing of recombinant proteins in anchorage dependent cells.
|